分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Degrading Ochratoxin A and Zearalenone Mycotoxins Using a Multifunctional Recombinant Enzyme

Md Shofiul Azam, Dianzhen Yu, Na Liu, Aibo Wu

Journal:Toxins

IF:3.9

DOI:10.3390/toxins11050301

PMID:31137857

Published:2019-05-27

research field:分子生物学毒理学真菌学生物技术

Abstract

Zearalenone (ZEA) is an estrogenic and ochratoxin A (OTA) is a hepatotoxicFusariummycotoxin commonly seen in cereals and fruits products. No previous investigation has studied on a single platform for the multi degradation mycotoxin. The current study aimed to investigate the bifunctional activity of a novel fusion recombinant. We have generated a recombinant fusion enzyme (ZHDCP) by combining two single genes named zearalenone hydrolase (ZHD) and carboxypeptidase (CP) in frame deletion by crossover polymerase chain reaction (PCR). We identified enzymatic properties and cell cytotoxicity assay of ZHDCP enzyme. Our findings have demonstrated that ZEA was completely degraded to the non-toxic product in 2 h by ZHDCP enzyme at an optimum pH of 7 and a temperature of 35 °C. For the first time, it was found out that ZEA 60% was degraded by CP degrades in 48 h. Fusion ZHDCP and CP enzyme were able to degrade 100% OTA in 30 min at pH 7 and temperature 30 °C. ZEA- and OTA-induced cell death and increased cell apoptosis rate and regulated mRNA expression of Sirt1, Bax, Bcl2, Caspase3, TNFα, and IL6 genes. Our novel findings demonstrated that the fusion enzyme ZHDCP possess bifunctional activity (degrade OTA and ZEA), and it could be used to degrade more mycotoxins.Keywords:fusion enzyme;ochratoxin A;carboxypeptidase;zearalenone;ZHD101;HK293 cell;LX2 cellKey Contribution:The novel multifunctional recombinant fusion enzyme (ZHDCP) could affect ZEA and OTA’s biotransformation ability. The final products from enzymatic degradation are less harmful than the mother compound, and reduced cell death and mitochondrial apoptosis.

本文使用的Yeasen产品

购物车
客服
转染试用